Feb. 07, 2017News & Opinions
Belgian chemical group Solvay has acquired DuPont’s Energain lithium-ion high voltage technology for an undisclosed sum. The Brussels-headquartered company said Energain will expand its Special Chem Global Business Unit’s ...
Feb. 07, 2017Topics
Ten years ago, in March 2007, oxo chemicals producer Oxea was established as a buyout led by private-equity firm Advent International of oxo derivatives and oxo intermediates businesses from Celanese and European Oxo. In December 2013, ...
Feb. 01, 2017News & Opinions
Novo Nordisk has announced plans to invest 1 billion Danish kroner ($145 million) over 10 years in a new research center at the University of Oxford, giving a major boost to the UK’s life sciences sector.
Jan. 26, 2017News & Opinions
BASF has launched what it says is a “range of new solutions” to fight disease, weeds and insects in Indian rice crops, thus boosting the productivity and income of farmers on the Asian subcontinent. Rice is India’s most ...
Jan. 25, 2017News & Opinions
Closing of the $130 billion merger between US chemical majors Dow and DuPont now appears unlikely before late in the 2017 third quarter, DuPont CEO Ed Breen said in a conference call to present 2016 financial results. The CEO’s ...
Jan. 18, 2017News & Opinions
A second chemical-pharmaceuticals company may have won points toward US approval of its mega-merger plans by making promises of research spending and job creation to President-elect Donald Trump.
Jan. 11, 2017News & Opinions
On the rebound from its failed drive to acquire Salix Pharmaceuticals from Canadian drugmaker Valeant in November 2016 – Valeant decided to keep the company – Japanese pharmaceutical producer Takeda has agreed to acquire ...
Jan. 09, 2017News & Opinions
Actelion and Johnson & Johnson may be edging closer to a deal that would give the US healthcare giant at least a major chunk of the Swiss biotech firm, according to the Zurich newspaper Tagesanzeiger.
Jan. 06, 2017News & Opinions
Ireland-headquartered drugmaker Shire Pharmaceuticals has sold its messenger RNA (mRNA) therapy platform MRT to US firm RaNA Therapeutics. Financial details were not revealed, but Shire will retain an undisclosed stake in the privately ...
Jan. 04, 2017News & Opinions
French isocyanates producer Vencorex, a joint venture between Thailand’s PTT Global Chemical with 51% and Sweden’s Perstorp with 49%, has announced the completion of several projects in France, Thailand and the US.
The latest information directly via newsletter.